Kurt Buechler
Psychiatry · Ridgeland, MSNPI 1922146760
Payments from drug & device makers
Across 1,953 payments — averaging $566.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$550K
- Vanda Pharmaceuticals Inc.$214K
- Axsome Therapeutics, Inc.$212K
- Otsuka America Pharmaceutical, Inc.$58K
- Takeda Pharmaceuticals U.S.A., Inc.$39K
- Eisai Inc.$27K
- plus $7K from 19 others
What the payments were for
- Consulting fees$69,4506%
- Speaking & faculty fees$859,83178%
- Travel & lodging$147,03313%
- Food & beverage$30,6563%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 901 | $550,364 |
| Vanda Pharmaceuticals Inc. | 327 | $213,996 |
| Axsome Therapeutics, Inc. | 260 | $212,268 |
| Otsuka America Pharmaceutical, Inc. | 128 | $57,826 |
| Takeda Pharmaceuticals U.S.A., Inc. | 95 | $38,825 |
| Eisai Inc. | 59 | $26,514 |
| Johnson & Johnson | 31 | $3,688 |
| Tris Pharma Inc | 32 | $708 |
| Supernus Pharmaceuticals, Inc. | 28 | $612 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $359 |
| Ironshore Pharmaceuticals Inc. | 16 | $327 |
| Jazz Pharmaceuticals Inc. | 11 | $298 |
| E.r. Squibb & Sons, L.L.C. | 10 | $226 |
| Merck | 11 | $165 |
| Lundbeck LLC | 7 | $151 |
| Collegium Pharmaceutical, Inc. | 7 | $133 |
| Avanir Pharmaceuticals, Inc. | 2 | $133 |
| Teva Pharmaceuticals USA, Inc. | 6 | $131 |
| Neurocrine Biosciences, Inc. | 5 | $95 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $49 |
| Corium, LLC | 1 | $29 |
| Arbor Pharmaceuticals, Inc. | 2 | $26 |
| Harmony Biosciences LLC | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Janssen Scientific Affairs, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$540,799
- Fanapt$209,473
- Auvelity$190,650
- REXULTI$55,728
- Dayvigo$26,078
- VYVANSE$21,403
- SUNOSI$18,233
- TRINTELLIX$16,131
- SPRAVATO$3,128
- CAPLYTA$126
- QELBREE$121
- NUEDEXTA$119
- Quillichew ER$107
- Quillivant$107
- Dyanavel XR$107
How this compares
$1,106,971 in reported general payments places this provider in the 95th percentile of 219 psychiatry providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 21 | $31,381 |
| AuvelityDextromethorphan Hbr/Bupropion | 18 | $20,400 |
| TrintellixVortioxetine Hydrobromide | 21 | $9,962 |
| SunosiSolriamfetol Hcl | 11 | $9,439 |
| Quetiapine Fumarate | 64 | $2,196 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 25 | $1,245 |
| Buspirone Hcl | 59 | $1,094 |
| Lamotrigine | 60 | $956 |
| Clonazepam | 111 | $633 |
| Ramelteon | 17 | $618 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 39 | $542 |
| Aripiprazole | 15 | $532 |
| Duloxetine Hcl | 23 | $509 |
| Bupropion XlBupropion Hcl | 26 | $453 |
| Temazepam | 13 | $452 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $550,364 | $31,38121 claims |
| Axsome Therapeutics, Inc.Auvelity, Sunosi | $212,268 | $29,83929 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $38,825 | $9,96221 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 219 psychiatry providers in Mississippi.
Other psychiatry in Ridgeland
- Clyde GlennRidgeland$231K
- Mark WebbRidgeland$12K
- Susan YoungerRidgeland$8K
- Mark McLainRidgeland$6K
- Fawaz AbdrabboRidgeland$4K
- Avani PatelRidgeland$4K
- Joseph KwentusFlowood$5M
- Maxie GordonClinton$1.3M
- Chasity TorrenceWhitfield$834K
- Jon JacksonJackson$834K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.